Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Company Info
Headquarters
Number of Employees
Revenue (in millions)
Contact Info
Visit Website
Tagline
Overview
Company Services
Site Information
Contributors
Contributions
Investment
Abzena Invests $60m into cGMP Manufacturing Capacity
PR-M10-20-06
Antibody-Drug Conjugate
Integrating ADC Manufacturing for the Future
PAP-Q2-2019-CL-002
Appointment
Abzena Announces $20m Investment into Expansion of Integrated Biotherapeutics Offering (Biologics Drug Substance and ADC) and Makes Key Executive Appointment
PR-M11-18-NI-036
Engineering Agreement
Abzena Signs Protein Engineering Agreement with NYU Langone Health
PR-M08-18-NI-036
Bioconjugation
Abzena and Telix sign strategic manufacturing and bioconjugation agreement
PR-M07-18-NI-016
Expanded Capacity
Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site
PR-M03-18-NI-105
Cell Line
Abzena Strengthens Specialized Bioassay Offering Through Access Agreement with Major Cell Line Depository
PR-M03-18-NI-053
Supplier
Abzena Selects Sartorius Stedum Biotech as Supplier of Single-Use Tech
PAO-M01-18-NI-033
Expansion
Abzena Continues to Expand Globally
PAO-M01-18-NI-025
Expanded Capacity
Abzena Takes on New Facilities in Cambridge, UK and San Diego
PR-M01-18-NI-013
Partnership
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol
PR-M01-18-NI-011
Cell Line Development
Abzena and UGA Team Up to Develop MS Therapeutic
PAO-M10-17-NI-033
Capacity Expansion
Facility Expansion at Abzena
PTV-M06-17-BIO-017
Oncology
Telix and OBI License Abzena Cancer Fighters
PAO-M07-17-NI-029
Biopharmaceutical
Abzena on the Road to BIO: Fueling Biopharmaceutical Development
PTV-M06-17-CL-006
Biologics
Propagating a Full Spectrum of Services for ADC Development and Manufacture
PAP-Q2-17-CL-007